Form 8-K - Current report:
SEC Accession No. 0000950123-06-008872
Filing Date
2006-07-12
Accepted
2006-07-12 15:39:32
Documents
5
Period of Report
2006-07-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y23176e8vk.htm 8-K 16151
2 EX-10.1: FORM OF RESTRICTED STOCK AGREEMENT FOR EXECUTIVE OFFICERS y23176exv10w1.htm EX-10.1 13367
3 EX-10.2: FORM OF RESTRICTED STOCK AGREEMENT FOR NON-MANAGEMENT DIRECTORS y23176exv10w2.htm EX-10.2 11993
4 EX-10.3: FORM OF RESTRICTED STOCK UNIT AGREEMENT FOR EXECUTIVE OFFICERS y23176exv10w3.htm EX-10.3 14451
5 EX-10.4: FORM OF RESTRICTED STOCK UNIT AGREEMENT FOR NON-MANAGEMENT DIRECTORS y23176exv10w4.htm EX-10.4 13882
  Complete submission text file 0000950123-06-008872.txt   71445
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 06958461
SIC: 2835 In Vitro & In Vivo Diagnostic Substances